Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia-Reference-Cited by-同舟云学术

Once-monthly paliperidone palmitate in recently diagnosed and chronic non-acute patients with schizophrenia

Published:2016-05-09 Issue:8 Volume:17 Page:1043-1053
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Hargarter L¹,Bergmans P²,Cherubin P³,Keim S⁴,Conca A⁵,Serrano-Blanco A⁶,Bitter I⁷,Bilanakis N⁸,Schreiner A¹

Affiliation:

1. Medical & Scientific Affairs, Janssen Cilag EMEA, Neuss, Germany

2. Biometrics & Reporting, Janssen Cilag Benelux, Tilburg, The Netherlands

3. Medical Affairs, Janssen Cilag EMEA, Issy-les-Moulineaux, France

4. Global Clinical Operations EMEA MAO, Janssen Cilag, Barcarena, Portugal

5. Department of Psychiatry, General Hospital, Bolzano, Italy

6. Acute Inpatient Unit, Parc Sanitari Sant Joan de Déu, Barcelona, Spain and redIAPP, Spain

7. Department of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary

8. Department of Psychiatric, General Hospital of Arta, Arta, Greece

Funder

Janssen Cilag

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://tandfonline.com/doi/pdf/10.1080/14656566.2016.1174692

Reference53 articles.

1. American Psychiatric Association. Practice Guideline For The Treatment of Patients With Schizophrenia. 2004. [cited 2016 Mar 09]. Available at: http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/schizophrenia.pdf.

2. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: A systematic review

3. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis

4. Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years

5. Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Long-Term Safety and Tolerability Study of TV-46000 for Subcutaneous Use in Patients with Schizophrenia: A Phase 3, Randomized, Double-Blinded Clinical Trial;CNS Drugs;2024-07-02

2. Characteristics of patients with schizophrenia switching from oral antipsychotics to once-monthly paliperidone palmitate (PP1M): a systematic review;BMC Psychiatry;2024-01-19

3. Efficacy and safety of TV-46000, a long-acting, subcutaneous, injectable formulation of risperidone, for schizophrenia: a randomised clinical trial in the USA and Bulgaria;The Lancet Psychiatry;2023-12

4. The effect of early or late initiation of long-acting antipsychotics on the caregiver burden in schizophrenia;International Clinical Psychopharmacology;2023-11-20

5. Effectiveness and Safety of Switching from Oral Antipsychotics to Once-Monthly Paliperidone Palmitate (PP1M) in the Management of Schizophrenia: A Systematic Review and Meta-Analysis;CNS Drugs;2023-07-25